Aptose Biosciences Inc. - APTOF

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2025 · Q4 2024
Value (USD)
Total reported value ($000)
$102K
QoQ value delta ($000)
-$207K (-66.99%)
Implied price effect (QoQ)
+1276.23%
Shares
Total shares
33,173
QoQ shares delta
-1,349,862 (-97.6%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (APTOF)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2025)

Top 25 only Full list
Early Q2 2026 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Sigma Planning Corp 54 17,389 0.0%
CITADEL ADVISORS LLC 38 12,007 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 6 2,060 0.0%
ROYAL BANK OF CANADA 4 1,351 0.0%
JPMORGAN CHASE & CO 0 36 0.0%
DANSKE BANK A/S 0 4 0.0%
MORGAN STANLEY 0 101 0.0%
NATIONAL BANK OF CANADA /FI/ 0 93 0.0%
GROUP ONE TRADING LLC 0 3 0.0%
SBI Securities Co., Ltd. 0 4 0.0%
TD Waterhouse Canada Inc. 0 22 0.0%
Federation des caisses Desjardins du Quebec 0 103 0.0%